Blog

10 Key Factors for HealthTech and MedTech founders to consider in today's M&amp;A market environmentThe top 10 key factors for HealthTech and MedTech founders to consider in today's M&amp;A market, focusing on value drivers and due diligence preparation, are:1. Proprietary AI and Innovation 🤖Companies with proven, proprietary AI/ML algorithms, especially in areas like diagnostics, predictive analytics, and surgical robotics, are seeing premium valuations (e.g., 6-8x revenue). Buyers are actively seeking these cutting-edge technologies. Founder Focus: Clearly document and protect your unique AI/tech "moat." Be ready to demonstrate measurable outcomes and efficiency gains it provides.2. Regulatory Compliance and Data Privacy 🔒Due diligence is highly focused on regulatory risk. Any deficiencies in adherence to laws like HIPAA, GDPR,Stark Law, or in your formal Quality Management System (QMS) can severely reduce valuation or kill a deal. Founder Focus: Ensure meticulous documentation and a flawless track record of compliance. Clearly define and prove your data security and privacy protocols.3. Strong and Predictable Financial Metrics 📈Buyers prioritise financial health. Key drivers are sustainable revenue growth, high gross margins, and a significant percentage of recurring revenue (e.g., SaaS or subscription models). Founder Focus: Clean up your financials. Shift toward recurring revenue models and demonstrate a clear path to profitability or strong unit economics.4. Demonstrable Clinical and Commercial Validation 🔬Unlike general tech, healthtech/medtech value is tied to real-world efficacy. Buyers require robust, documented clinical studies and clear Return on Investment (ROI) for providers and payers. Founder Focus: Invest in generating high-quality clinical evidence. Document case studies that prove your product's impact on patient outcomes and cost savings.5. Clear Intellectual Property (IP) Ownership 🛡️Your IP is your core asset. Gaps in ownership—such as lack of "work for hire" agreements with contractors or missing employee IP assignment clauses—will be a major red flag during due diligence. Founder Focus: Conduct an internal IP audit. Ensure all patents, trademarks, and code ownership are legally clear, assigned to the company, and fully defensible.6. Alignment with Value-Based Care (VBC) 🤝Healthcare is shifting from fee-for-service to VBC. Companies that enable this transition (e.g., remote patient monitoring, population health, chronic disease management) are strategically valuable to payers and providers. Founder Focus: Frame your solution in terms of how it reduces costs and improves patient outcomes, directly supporting a VBC model.7. Scalable Processes and Management Team Depth 👥Buyers assess "key person risk." Over-reliance on the founder for key client relationships or daily operations raises concerns about post-acquisition sustainability. Founder Focus: Build a strong second-tier management team and document repeatable Standard Operating Procedures (SOPs). Prove the company can run and scale without the founders' constant involvement.8. Interoperability and Data Monetization Strategy 🔗The ability to seamlessly integrate with Electronic Health Records (EHRs) and other systems (interoperability) is crucial. Companies with clean, actionable data that can be ethically leveraged (monetization) command higher multiples. Founder Focus: Prioritize API development and integration capabilities. Demonstrate a clear, compliant strategy for how your data creates additional value.9. Customer Concentration and Acquisition Costs (CAC) 🎯High customer concentration (revenue dependent on one or two clients) signals a major risk to a buyer. Low Customer Acquisition Costs (CACs) are a key profitability driver. Founder Focus: Diversify your customer base to reduce concentration risk. Optimize your sales and marketing process to prove an efficient, scalable, and low CAC model.10. Understanding Alternative Deal Structures 💰To bridge valuation gaps between buyers and sellers, alternative structures are becoming common. These include earn-outs (additional payments based on future performance) and royalty/licensing agreements. Founder Focus: Be prepared to negotiate a portion of your deal value into an earn-out structure, especially if a buyer is cautious about future revenue projections. This shows confidence in your team and product's future performance.To discuss how Nelson Advisors can help your HealthTech or MedTech company, please email <a data-mce-href="mailto:lloyd@nelsonadvisors.co.uk" href="mailto:lloyd@nelsonadvisors.co.uk" title="lloyd@nelsonadvisors.co.uk" target="_blank" rel="noopener" data-mce-selected="inline-boundary">lloyd@nelsonadvisors.co.uk</a>

10 Key Factors for HealthTech and MedTech founders to consider in today's M&A market environment

October 2025 - small spiral desktop calendar, time and business concept

The major stories in the world of European MedTech this week are dominated by regulatory activity under the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR), a significant European Commission "Call for Evidence" for future reforms, and fresh funding for companies focused on connected and remote monitoring devices.Here are the top stories:1. Regulatory Pressure and Calls for MDR/IVDR Reform The central theme this week is the ongoing industry push for revisions and accommodations within the European Union's medical device regulations (MDR/IVDR):EU Call for Evidence for MDR/IVDR Future: The European Commission launched a "Call for Evidence" on the future of the MDR/IVDR, specifically a targeted revision aimed at reducing administrative burden, improving predictability, and enabling digitalisation. The deadline for industry feedback is October 6, 2025, making this the most time-sensitive policy story this week. MedTech Europe's Push for Immediate Action: The industry body, MedTech Europe, continued to press the EU for immediate regulatory changes by early 2026. Their requests include:A targeted postponement of re-certification requirements for devices already certified under the existing regulations to avoid a "new major bottleneck" before the 2028 deadline. The creation of a single, accountable governance structure to oversee the network of Notified Bodies (NBs), aiming to ensure a more efficient and globally competitive CE-marking system. The launch of planned pilots for expedited regulatory pathways for orphan, pediatric, and breakthrough devices. Regulatory Milestones: The industry saw updates on several detailed compliance issues:Confirmation of the Master UDI-DI (Unique Device Identification) implementation date for contact lenses being postponed to November 9, 2026. Publication of new guidance on addressing incomplete Technical Files for IVDR submissions from Team-NB. Updates on the status of MDR/IVDR implementation and the gradual rollout of the EUDAMED database. 2. MedTech Product Rollout and Commercial Growth Cardiology Device Rollout: Elixir Medical began its full European rollout of the LithiX high-capacity Intravascular Lithotripsy (IVL) device following its CE mark, with over 400 patients already treated across 16 countries. This marks a significant market entry for a new cardiology technology. 3. Key MedTech Funding and Expansion Recent funding activity highlights strong investment interest in both digital and hardware-based medical solutions:Remote Monitoring Device Funding: RDS (France) raised a €14 million Series A round to industrialise and expand its MultiSense RDS, a CE-marked connected patch for continuous remote patient monitoring across Europe. AI for Veterinary MedTech: Lupa (UK) secured a €17 Million Series A to scale its AI-native operating system for veterinary clinics and launch a dedicated Veterinary AI Lab in Europe, demonstrating the spread of MedTech innovation into adjacent healthcare sectors. Big Tech Investment in Surgical Robotics: Medtronic plc announced it is doubling its London presence to create a global hub for surgical robotics and AI, aligning with the ambitions of the NHS 10-Year Health Plan. 4. Broader Context and Industry Movement Staffing and Leadership: Dentsply Sirona appointed a new EVP &amp; Chief Commercial Officer to align its global business units with commercial execution, with the new executive bringing extensive experience from J&amp;J MedTech. Global Trade Impact: European medtech firms are closely watching the potential impact of a US Section 232 investigation and its potential to introduce tariffs, particularly monitoring whether it could override the Nairobi Protocol, which bans tariffs on products for people with disabilities.To discuss how Nelson Advisors can help your HealthTech or MedTech company, please email <a data-mce-href="mailto:lloyd@nelsonadvisors.co.uk" href="mailto:lloyd@nelsonadvisors.co.uk" title="lloyd@nelsonadvisors.co.uk" target="_blank" rel="noopener" data-mce-selected="inline-boundary">lloyd@nelsonadvisors.co.uk</a>

This Week in European MedTech - Week 1 October 2025

October 2025. Resolution, strategy, solution, goal, business and holidays. Date month October 2025. Monthly desk calendar October 2025. planning new year

The top stories in European HealthTech this week are heavily focused on AI adoption, major regulatory milestones, and significant funding activity.Here are the key highlights:1. AI Regulation Breakthrough for Autonomous Care AI Physiotherapist Approved for Autonomous Decisions: A significant development saw Flok Health's AI-powered physiotherapy clinic secure Class IIa Medical Device approval under EU regulations. This is a major regulatory milestone, as it grants the AI system clearance to make diagnostic and treatment decisions without human supervision, effectively delivering an entire end-to-end care pathway autonomously. This is reported to be the first time an AI system in the UK or Europe has been approved for fully autonomous end-to-end care. 2. Notable Funding Rounds The week has seen fresh capital injection for AI-powered and wellness platforms:Simple Life's Major Series B: The London-based wellness and fitness app, Simple Life, secured a $35 million Series B funding round to scale its AI health coach platform. praxipal's Seed Funding: Berlin-based startup praxipal landed $6.7 million to continue building its AI workforce designed for healthcare front desks in Germany. Vocca's Seed Round: The voice AI startup Vocca raised $5.5 million in seed funding to bring AI phone assistants to the healthcare sector. DaltonTx Seed Funding: UK-based technology company DaltonTx exited stealth and completed a £4 million seed round to advance its intelligence backbone for drug discovery. 3. Focus on Digital Health in Healthcare Systems (Primarily UK/NHS) Major Digital Strategy and Procurement: Several health systems across the UK are pushing forward with significant digital transformation projects:University Hospitals Birmingham is seeking a £2 million integrated digital patient pathway platform. GOSH (Great Ormond Street Hospital) shared a study into an AI scribe pilot across nine London NHS sites, and also outlined its comprehensive AI strategy roadmap. Lincolnshire Community and Hospitals NHS Group launched its digital strategy to 2028. Pilot data showed that Flok Health's AI physiotherapy platform had a measurable impact, more than halving waiting lists for back pain at one NHS Trust. 4. Innovation in Diagnostics and Patient Monitoring Regulatory Approvals for Danish Startups:Evido Health obtained regulatory approval (CE-certificate, IVDR cl-b) for its data-driven clinical tool, LiverPRO, aimed at timely detection and intervention for Chronic Liver Disease (CLD). BrainCapture received CE marking for its pioneering, affordable EEG solution. WARD 24/7 received FDA Clearance for its WARD-CSS® (Clinical Support System), a Software as a Medical Device (SaMD) for continuous patient monitoring. In summary, the European healthtech landscape is demonstrating strong momentum, particularly in the fields of AI-driven clinical applications with a landmark regulatory approval, sustained early-stage and growth-stage funding, and continuous digital modernization efforts within public healthcare systems.To discuss how Nelson Advisors can help your HealthTech or MedTech company, please email <a data-mce-href="mailto:lloyd@nelsonadvisors.co.uk" href="mailto:lloyd@nelsonadvisors.co.uk" title="lloyd@nelsonadvisors.co.uk" target="_blank" rel="noopener">lloyd@nelsonadvisors.co.uk</a>

This Week in European HealthTech - Week 1 October 2025

Adopting the Bamboo Mindset in HealthTech is crucial for navigating the industry's rapid changes, complex regulations, and patient centric demands. The bamboo's combination of flexibility, resilience, and steady growth provides a powerful model for innovation and operations in healthcare technology.Here are 10 reasons to adopt the 'Bamboo Mindset' in HealthTech:1. Adaptability to Regulatory ChangeThe healthcare industry is heavily regulated and subject to frequent policy shifts (e.g., HIPAA, Cures Act, value-based care models). The bamboo's flexibility to bend with the wind allows HealthTech companies to quickly pivot their product features, compliance frameworks, and business strategies without breaking under the pressure of new rules.2. Resilience to Setbacks and FailureInnovation in healthtech involves high stakes and high rates of failure, from unsuccessful pilot programs to lengthy FDA approval processes. The bamboo's ability to spring back after a storm cultivates a culture of antifragility, where teams learn from failures and emerge stronger, rather than being defeated.3. Patient Centric FlexibilityHealthcare needs are constantly evolving, especially with new public health crises and changing patient demographics. A flexible mindset ensures technology is not rigid, but can be easily modified to meet the nuanced and diverse needs of patients, providers, and payers, enabling personalized care solutions.4. Building a Strong Foundation (Interoperability)Like the bamboo developing an extensive root system before visible growth, HealthTech innovation must prioritize building a strong data and security infrastructure for interoperability. This unseen, foundational work ensures that when the product grows rapidly, it has the stable roots needed to connect with fragmented legacy systems across the healthcare ecosystem.5. Persistence and Long-Term VisionDeveloping impactful medical devices or clinically validated digital therapeutics requires years of research, testing, and validation—the "five years of waiting" seen in the Chinese Bamboo Tree. This mindset encourages persistence and faith in the process, preventing startups from abandoning critical projects due to a lack of immediate, high-speed returns.6. Continuous, Incremental Improvement (Kaizen)The rapid and continuous growth of bamboo reflects the need for continuous product iteration in HealthTech. Instead of waiting for massive, revolutionary updates, this mindset promotes the Japanese principle of Kaizen—making small, consistent, data-driven improvements to clinical workflows, user experience, and algorithm accuracy.7. Collaborative Ecosystem StrengthBamboo often grows in a thick grove, with interconnected roots providing collective strength. This translates to fostering cross-functional collaboration between clinicians, engineers, designers, and business leaders, and building an interconnected network with health systems, payers, and community organizations to address holistic patient care.8. Humility in InnovationThe hollow nature of the bamboo stalk can represent intellectual humility. In a sector where technology is augmenting—not replacing—human expertise (Intelligence Assistance), this mindset ensures innovators listen to and learn from clinicians and end-users, rather than being rigid and full of their own preconceptions.9. Efficient Use of ResourcesBamboo is known for its versatility and sustainability as a resource. In business, this translates to operational efficiency and creating high-value solutions using minimal or existing resources, which is vital in the budget-constrained healthcare environment.10. Rapid Scalability After ValidationOnce the foundational roots and persistent growth efforts are complete, the bamboo grows quickly. This symbolizes the ability to rapidly scale a HealthTech solution (product-market fit) only after it has been rigorously validated, clinically proven, and seamlessly integrated into existing workflows.To discuss how Nelson Advisors can help your HealthTech or MedTech company, please email <a data-mce-href="mailto:lloyd@nelsonadvisors.co.uk" href="mailto:lloyd@nelsonadvisors.co.uk" title="lloyd@nelsonadvisors.co.uk" target="_blank" rel="noopener">lloyd@nelsonadvisors.co.uk</a>

10 reasons to adopt the 'Bamboo Mindset' in HealthTech

Aerial view of Edinburgh old town, aerial view of the scottish flag in Edinburgh, Edinburgh city centre, Gothic Revival architecture in Scotland, Flag of Scotland in Edinburgh

Scotland is rapidly emerging as a rising hub for AI HealthTech due to a powerful blend of world-class academic research, a highly collaborative ecosystem with the National Health Service (NHS), and proactive government support focused on ethical data use and digital innovation.Key Factors Driving Growth 📈 World-Class Research and Talent: Scotland, particularly Edinburgh, is recognized as a leading hub for AI, rooted in over 60 years of cutting-edge research. Universities provide a strong pipeline of talent with AI and data science expertise, supported by numerous AI-related degrees and strong links between academia and industry. Unique Collaborative Ecosystem: The relatively small and connected nature of Scotland fosters strong collaboration between universities, startups, and the NHS. This environment is ideal for real-world testing and rapid deployment of new technologies. Organisations like CodeBase and Techscaler deliver support schemes, connecting academic founders and startups with mentors, NHS innovation hubs, and global investors. Access to Healthcare Data and Infrastructure: Efforts are underway to build a single national data architectureand unlock secure, ethical access to public sector data, which is crucial for training and developing AI health applications. The nation's extensive digital health records and focus on data-driven healthcare provide a competitive edge. Government Strategy and Support: The Scottish Government has made digital health a key priority, backing it with a National AI Strategy that emphasizes trustworthy, ethical, and inclusive innovation. Initiatives like the CivTech programme and the Techscaler AI Discovery accelerator provide funding and support to commercialise research into high-impact startups. Strong Historical Foundation: Scotland has a rich, 200-year history of medical innovation, which has translated into a thriving life sciences cluster of over 750 organisations. This legacy provides a fertile ground and experienced workforce for the next generation of AI-driven HealthTech. &nbsp; Major Hubs, Companies and Research Centres Industrial Centre for Artificial Intelligence Research in Digital Diagnostics (iCAIRD): A major pan-Scotland collaboration that brings together industry (like Canon Medical Research and Royal Philips), the NHS, and universities (including Edinburgh, Glasgow, and Aberdeen) to apply AI in digital diagnostics, pathology, and radiology. It works to digitise NHS pathology data and develop secure research platforms. Digital Health &amp; Care Innovation Centre (DHI): A key enabler and catalyst for change, facilitating collaborations between commercial, academic, and healthcare sectors to expedite the adoption of digital health and social care solutions. Universities: Institutions like the University of Edinburgh and the University of Strathclyde host significant research centres and accelerators, such as the Venture Builder Incubator and the HealthTech Cluster, focusing on areas like digital health, AI, and medical devices. Companies and Startups:Blackford Analysis: Offers a platform to simplify the selection, deployment, and management of AI medical imaging applications. Aridhia: Provides digital research environments for biomedical and healthcare researchers, facilitating secure, cloud-enabled data analysis. Infix Support: A Glasgow-based startup developing an AI-powered platform to improve operating theatre efficiency across NHS Scotland. Current Health: An Edinburgh-based care-at-home platform that achieved a significant exit when acquired by Best Buy in 2021.To discuss how Nelson Advisors can help your Health AI company, please email <a data-mce-href="mailto:lloyd@nelsonadvisors.co.uk" href="mailto:lloyd@nelsonadvisors.co.uk" title="lloyd@nelsonadvisors.co.uk" target="_blank" rel="noopener" data-mce-selected="inline-boundary">lloyd@nelsonadvisors.co.uk</a>

Scotland is rapidly emerging as a rising hub for AI HealthTech

IBIS Capital are excited to announce that Lloyd Price, Partner and Co-Founder of Nelson Advisors, will be joining us at the HealthTechX Summit!Lloyd is a seasoned HealthTech entrepreneur and investor, with 12+ years of experience founding and exiting companies, including Zesty, acquired by Induction Healthcare Group (FTSE:INHC). He now advises and mentors the next wave of digital health innovators through roles at UCL Global Business School for Health, Oxford Venture Capital Network, and beyond.At HealthTechX, Lloyd will join the panel “International Investors and European HealthTech", sharing his insights on scaling, investing, and building successful healthtech ventures.Don’t miss the chance to hear from Lloyd and other leaders shaping the future of healthcare.👉 Register now to secure your spot: <a data-mce-href="https://lnkd.in/e7CyWeWR" href="https://lnkd.in/e7CyWeWR" title="https://lnkd.in/e7CyWeWR" target="_blank" rel="noopener">https://lnkd.in/e7CyWeWR</a>HealthTechX Summit 2025Date: Wednesday, November 5, 2025 Location: The Hurlingham Club, Ranelagh Gardens, London SW6 3PR The annual summit is a one-day event that brings together founders, CEOs, investors, and policymakers in the health technology sector to discuss key trends and drive innovation.To discuss how Nelson Advisors can speak on a panel, chair the discussions or attend &nbsp;your MedTech or HealthTech event, please email <a data-mce-href="mailto:lloyd@nelsonadvisors.co.uk" href="mailto:lloyd@nelsonadvisors.co.uk" title="lloyd@nelsonadvisors.co.uk" target="_blank" rel="noopener" data-mce-selected="inline-boundary">lloyd@nelsonadvisors.co.uk</a>

Nelson Advisors

Blog

10 Key Factors for HealthTech and MedTech founders to con...

This Week in European MedTech - Week 1 October 2025

This Week in European HealthTech - Week 1 October 2025

10 reasons to adopt the 'Bamboo Mindset' in HealthTech

Scotland is rapidly emerging as a rising hub for AI Healt...

Nelson Advisors invited as a speaker on the “Internationa...